Cross-Regional Trajectory Analysis Reveals Distinct Temporal Progression of Shared Proteomic Programs in Alzheimer's Disease
Gao, T.; Upadhyaya, Y.; Pan, Y.; Nho, K.; Saykin, A. J.; Yan, J.
Show abstract
Alzheimer's pathology progresses through anatomically distinct brain regions, yet how molecular programs are temporally organized across vulnerable regions remains poorly understood. Here, we reconstructed continuous proteomic trajectories from matched dorsolateral prefrontal cortex (DLPFC) and superior temporal gyrus (STG) proteomes to investigate cross-regional molecular progression in AD. The inferred trajectories closely recapitulated established neuropathological staging while remaining independent of age, sex, and race. Across regions, a mitochondrial bioenergetic protein subset declined substantially earlier in the STG than in the DLPFC, revealing a previously unrecognized regional temporal offset in metabolic dysfunction. In parallel, a broadly shared proteomic program progressed in both regions but more rapidly in the STG, indicating that shared molecular responses differ in their temporal progression despite overall coordination. Together, these findings demonstrate that regional vulnerability in AD is reflected not only by the molecular programs involved but also by their temporal organization during disease progression.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Neuro-Metabolic and Vascular Dysfunction as an Early Diagnostic for Alzheimer's Disease and Related Dementias. 96%
- Multiscale Metabolic Covariance Networks Uncover Stage-Specific Biomarker Signatures Across the Alzheimer's Disease Continuum. 94%
- Mapping cross-domain drivers of Alzheimer's disease risk through integrated network analysis 94%
Similar papers in this journal
Similar papers in this journal
- Psychosocial experiences are associated with human brain mitochondrial biology 94%
- Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease 93%
- ACSS2 upregulation enhances neuronal resilience to aging and tau-associated neurodegeneration 93%
Similar papers in this journal
- Integration of aged brain multi-omics reveals cross-system mechanisms underlying Alzheimer's disease heterogeneity 97%
- Small tau aggregates exhibit disease-specific molecular profiles across tauopathies 96%
- Alzheimer’s patient brain myeloid cells exhibit enhanced aging and unique transcriptional activation 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.